CI

At a glance

ClinicalIndex Comparison Record
N/ARecruiting· 200 target
Drug / intervention
SPLICEother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07226115
NCT07226115N/ARecruitingOn TrackUpdated 7mo ago

Splicing-Based Predictive Learning for Individual Chemotherapy Evaluation in Colorectal Cancer (SPLICE)

City of Hope Medical Center·observational·Posted Nov 10, 2025·Updated Nov 10, 2025

In Brief

An observational study evaluating SPLICE for Colorectal Cancer and 3 related conditions. Currently recruiting, targeting 200 participants across 1 site.

Detailed Summary

Colorectal cancer (CRC) remains one of the leading causes of cancer-related mortality worldwide. Although adjuvant chemotherapy improves survival after curative resection, its efficacy varies widely among patients. The absence of reliable predictive biomarkers often leads to overtreatment or undertreatment. This study aims to develop a machine learning-based predictive model for adjuvant chemotherapy response using tumor-derived alternative splicing signatures. By integrating RNA-seq data, splicing isoform and clinical outcomes, this study seeks to identify molecular predictors of treatment response and recurrence risk after surgery.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ARecruitingOverdue
20252026
First PostedNov 10, 2025
Enrollment StartJun 21, 2024
Primary CompletionJun 18, 2026
TodayJul 1, 2026
Enrollment to primary: 2.0 yearsPosted 8 months ago

Interventions

SPLICEother

A panel of RNA splicing isoform, whose level is tested in tissue samples derived from the primary tumor.